AAM
DXCM icon

Alken Asset Management’s DexCom DXCM Stock Holding History

Alken Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,200
Closed -$492K – 37
2025
Q1 		$492K Sell
7,200
-2,800
-28% -$228K 0.8% 33
2024
Q4 		$777K Hold
10,000
– – 1.47% 27
2024
Q3 		$0 Buy
+10,000
New +$821K ﹤0.01% 32

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Alken Asset Management's DXCM Position: Q2 2025 in Review

Alken Asset Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 7,200 shares — an estimated $492K sold.

Alken Asset Management first reported a position in DXCM in Q3 2024 and held it in 3 quarters. The position peaked at $777K in Q4 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Alken Asset Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Alken Asset Management sold 7,200 DexCom shares in Q2 2025, an estimated $492K.
  • Alken Asset Management first reported a position in DexCom in Q3 2024 and held it in 3 quarters.
  • Alken Asset Management's DexCom position peaked at $777K in Q4 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Alken Asset Management's 13F filing for Q2 2025, filed 9 Jul 2025.